Drug intelligence / Profile preview

normothermic ex-vivo kidney perfusion solution - toronto

Development stage
Unknown
Lead developer
University Health Network
Modality
Peptides, Small Molecules
Administration
Parenteral
01

Overview

Normothermic ex-vivo kidney perfusion Solution -Toronto is a specialized preservation and perfusion fluid developed by the University Health Network (UHN) in Toronto for use in normothermic ex vivo machine perfusion (NEVKP) of donor kidneys. Unlike traditional static cold storage, this solution is designed to be used at physiological temperatures (37°C) to maintain the metabolic activity of the kidney outside the body. The solution typically contains a combination of oxygen carriers (often packed red blood cells), electrolytes, nutrients, and medications to support organ function, allow for viability assessment, and potentially repair injury sustained during the donation process. It is primarily investigated for its ability to improve outcomes in high-risk donor kidneys and reduce the incidence of delayed graft function (DGF) in recipients with end-stage renal disease.

Other names
Toronto NEVKP solutionNormothermic ex vivo kidney perfusion solution
02

Targets

INSR (Insulin receptor)ATIII (Antithrombin III)

Beyond the preview

Go deeper on normothermic ex-vivo kidney perfusion solution - toronto.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on normothermic ex-vivo kidney perfusion solution - toronto.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call